Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Medistim ASA
MD1Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which is designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation of fragile or calcified vessels; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway. Address: Økernveien 94, Oslo, Norway, 0579
Analytics
Objectif de Cours de WallStreet
2 036.26 NOKRatio C/B
32.2807Rendement du dividende
2.45 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés MD1
Analyse des dividendes MD1
Croissance des dividendes sur 5 ans
125 %Croissance continue
9 annéesRatio de distribution Moyenne sur 5 ans
105 %Historique des dividendes MD1
Valorisation des titres MD1
financières MD1
Résultats | 2019 | Dynamique |